News
$ImmunityBio(IBRX.US$ Immunitybio Announced Data From Phase 1 Pilot Study Showed N-803 Combined With Natural Killer Cells Could Reduce Viral Load In People Living With HIV
Moomoo 24/7· just
All participants in the Phase 1 pilot study experienced a marked decrease in the burden of infection, and the procedures were found to be safe and well tolerated
N-803 is being studied in three other HIV cure-related clinical trials
Moomoo 24/7· just
All participants in the Phase 1 pilot study experienced a marked decrease in the burden of infection, and the procedures were found to be safe and well tolerated
N-803 is being studied in three other HIV cure-related clinical trials
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
MAbd : Buy?
Trytosaveabit OP MAbd : That’s one thing I don’t do! Buy/sell advice! No way for me to know each person’s risk tolerance! Or the type of trade? Day trade, swing trade or momentum trade! All 3 have different criteria for entry and exit! Hope you understand? GL